Loading...

Joseph Wong, MD

Address4150 Clement St
San Francisco CA 94121
Phone415-221-4810
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Northwestern University, Evanston, ILB.S.06/1980Honors Program in Med Education
    Northwestern University Medical School, Chicago, ILM.D.06/1982Medicine
    U.S. Naval Hospital, San Diego, CAInternship06/1983Internal Medicine
    McGaw Medical Ctr, Northwestern University, Chicago, ILResidency06/1989Internal Medicine
    UC San Diego, San Diego, CAFellowship06/1994Infectious Diseases

    Collapse Research 
    Collapse Research Activities and Funding
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R33AI116218Sep 1, 2016 - Aug 31, 2019
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R33AI116218Sep 1, 2016 - Aug 31, 2019
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R33AI116218Sep 1, 2016 - Aug 31, 2019
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R33AI116218Sep 1, 2016 - Aug 31, 2019
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R33AI116218Sep 1, 2016 - Aug 31, 2019
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R33AI116218Sep 1, 2016 - Aug 31, 2019
    Role: Principal Investigator
    Tissue Reservoirs of HIV in Victims of Sudden Death
    NIH/NIAID R56AI116342Jul 2, 2015 - Jun 30, 2016
    Role: Principal Investigator
    Tissue Reservoirs of HIV in Victims of Sudden Death
    NIH/NIAID R56AI116342Jul 2, 2015 - Jun 30, 2016
    Role: Principal Investigator
    Tissue Reservoirs of HIV in Victims of Sudden Death
    NIH/NIAID R56AI116342Jul 2, 2015 - Jun 30, 2016
    Role: Principal Investigator
    Tissue Reservoirs of HIV in Victims of Sudden Death
    NIH/NIAID R56AI116342Jul 2, 2015 - Jun 30, 2016
    Role: Principal Investigator
    Tissue Reservoirs of HIV in Victims of Sudden Death
    NIH/NIAID R56AI116342Jul 2, 2015 - Jun 30, 2016
    Role: Principal Investigator
    Tissue Reservoirs of HIV in Victims of Sudden Death
    NIH/NIAID R56AI116342Jul 2, 2015 - Jun 30, 2016
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R21AI116218Sep 1, 2014 - Aug 31, 2016
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R21AI116218Sep 1, 2014 - Aug 31, 2016
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R21AI116218Sep 1, 2014 - Aug 31, 2016
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R21AI116218Sep 1, 2014 - Aug 31, 2016
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R21AI116218Sep 1, 2014 - Aug 31, 2016
    Role: Principal Investigator
    Evaluating HIV expression and latency in blood and tissues at the single cell level
    NIH/NIAID R21AI116218Sep 1, 2014 - Aug 31, 2016
    Role: Principal Investigator
    Role of Gut Associated Lymphoid Tissue in HIV Persistence
    NIH/NIAID R56AI091573Sep 16, 2011 - Aug 31, 2013
    Role: Principal Investigator
    Role of Gut Associated Lymphoid Tissue in HIV Persistence
    NIH/NIAID R56AI091573Sep 16, 2011 - Aug 31, 2013
    Role: Principal Investigator
    Role of Gut Associated Lymphoid Tissue in HIV Persistence
    NIH/NIAID R56AI091573Sep 16, 2011 - Aug 31, 2013
    Role: Principal Investigator
    Role of Gut Associated Lymphoid Tissue in HIV Persistence
    NIH/NIAID R56AI091573Sep 16, 2011 - Aug 31, 2013
    Role: Principal Investigator
    Role of Gut Associated Lymphoid Tissue in HIV Persistence
    NIH/NIAID R56AI091573Sep 16, 2011 - Aug 31, 2013
    Role: Principal Investigator
    Role of Gut Associated Lymphoid Tissue in HIV Persistence
    NIH/NIAID R56AI091573Sep 16, 2011 - Aug 31, 2013
    Role: Principal Investigator
    The contribution of Tcell tolerance to latent HIV infection
    VA I01BX001048Oct 1, 2010 - Sep 30, 2014
    Role: Principal Investigator
    The contribution of Tcell tolerance to latent HIV infection
    VA I01BX001048Oct 1, 2010 - Sep 30, 2014
    Role: Principal Investigator
    The contribution of Tcell tolerance to latent HIV infection
    VA I01BX001048Oct 1, 2010 - Sep 30, 2014
    Role: Principal Investigator
    The contribution of Tcell tolerance to latent HIV infection
    VA I01BX001048Oct 1, 2010 - Sep 30, 2014
    Role: Principal Investigator
    The contribution of Tcell tolerance to latent HIV infection
    VA I01BX001048Oct 1, 2010 - Sep 30, 2014
    Role: Principal Investigator
    The contribution of Tcell tolerance to latent HIV infection
    VA I01BX001048Oct 1, 2010 - Sep 30, 2014
    Role: Principal Investigator
    Variation in Neurocognitive Impairment of HIV Ugandan Children by HIV Subtype
    NIH/NIMH R21MH083573Mar 25, 2008 - May 31, 2011
    Role: Principal Investigator
    Variation in Neurocognitive Impairment of HIV Ugandan Children by HIV Subtype
    NIH/NIMH R21MH083573Mar 25, 2008 - May 31, 2011
    Role: Principal Investigator
    Variation in Neurocognitive Impairment of HIV Ugandan Children by HIV Subtype
    NIH/NIMH R21MH083573Mar 25, 2008 - May 31, 2011
    Role: Principal Investigator
    Variation in Neurocognitive Impairment of HIV Ugandan Children by HIV Subtype
    NIH/NIMH R21MH083573Mar 25, 2008 - May 31, 2011
    Role: Principal Investigator
    Variation in Neurocognitive Impairment of HIV Ugandan Children by HIV Subtype
    NIH/NIMH R21MH083573Mar 25, 2008 - May 31, 2011
    Role: Principal Investigator
    Variation in Neurocognitive Impairment of HIV Ugandan Children by HIV Subtype
    NIH/NIMH R21MH083573Mar 25, 2008 - May 31, 2011
    Role: Principal Investigator
    HIV-1 Adaptation in the Central Nervous System
    NIH/NINDS R01NS051132Jul 15, 2005 - Jun 30, 2011
    Role: Principal Investigator
    HIV-1 Adaptation in the Central Nervous System
    NIH/NINDS R01NS051132Jul 15, 2005 - Jun 30, 2011
    Role: Principal Investigator
    HIV-1 Adaptation in the Central Nervous System
    NIH/NINDS R01NS051132Jul 15, 2005 - Jun 30, 2011
    Role: Principal Investigator
    HIV-1 Adaptation in the Central Nervous System
    NIH/NINDS R01NS051132Jul 15, 2005 - Jun 30, 2011
    Role: Principal Investigator
    HIV-1 Adaptation in the Central Nervous System
    NIH/NINDS R01NS051132Jul 15, 2005 - Jun 30, 2011
    Role: Principal Investigator
    HIV-1 Adaptation in the Central Nervous System
    NIH/NINDS R01NS051132Jul 15, 2005 - Jun 30, 2011
    Role: Principal Investigator
    IN VIVO HIV LATENCY REVEALED BY POTENT ANTIVIRAL THERAPY
    NIH/NIAID R01AI043752Apr 1, 1999 - Mar 31, 2005
    Role: Principal Investigator
    IN VIVO HIV LATENCY REVEALED BY POTENT ANTIVIRAL THERAPY
    NIH/NIAID R01AI043752Apr 1, 1999 - Mar 31, 2005
    Role: Principal Investigator
    IN VIVO HIV LATENCY REVEALED BY POTENT ANTIVIRAL THERAPY
    NIH/NIAID R01AI043752Apr 1, 1999 - Mar 31, 2005
    Role: Principal Investigator
    IN VIVO HIV LATENCY REVEALED BY POTENT ANTIVIRAL THERAPY
    NIH/NIAID R01AI043752Apr 1, 1999 - Mar 31, 2005
    Role: Principal Investigator
    IN VIVO HIV LATENCY REVEALED BY POTENT ANTIVIRAL THERAPY
    NIH/NIAID R01AI043752Apr 1, 1999 - Mar 31, 2005
    Role: Principal Investigator
    IN VIVO HIV LATENCY REVEALED BY POTENT ANTIVIRAL THERAPY
    NIH/NIAID R01AI043752Apr 1, 1999 - Mar 31, 2005
    Role: Principal Investigator
    CHARACTERIZING TISSUE SPECIFIC HIV DRUG RESISTANCE
    NIH/NIAID K11AI001361Aug 1, 1996 - Jul 31, 2001
    Role: Principal Investigator
    CHARACTERIZING TISSUE SPECIFIC HIV DRUG RESISTANCE
    NIH/NIAID K11AI001361Aug 1, 1996 - Jul 31, 2001
    Role: Principal Investigator
    CHARACTERIZING TISSUE SPECIFIC HIV DRUG RESISTANCE
    NIH/NIAID K11AI001361Aug 1, 1996 - Jul 31, 2001
    Role: Principal Investigator
    CHARACTERIZING TISSUE SPECIFIC HIV DRUG RESISTANCE
    NIH/NIAID K11AI001361Aug 1, 1996 - Jul 31, 2001
    Role: Principal Investigator
    CHARACTERIZING TISSUE SPECIFIC HIV DRUG RESISTANCE
    NIH/NIAID K11AI001361Aug 1, 1996 - Jul 31, 2001
    Role: Principal Investigator
    CHARACTERIZING TISSUE SPECIFIC HIV DRUG RESISTANCE
    NIH/NIAID K11AI001361Aug 1, 1996 - Jul 31, 2001
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Beliakova-Bethell N, Hezareh M, Wong JK, Strain MC, Lewinski MK, Richman DD, Spina CA. Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART. Virology. 2017 May 17; 508:127-133. PMID: 28527342.
      View in: PubMed
    2. Jiang G, Santos Rocha C, Hirao LA, Mendes EA, Tang Y, Thompson GR, Wong JK, Dandekar S. HIV Exploits Antiviral Host Innate GCN2-ATF4 Signaling for Establishing Viral Replication Early in Infection. MBio. 2017 May 02; 8(3). PMID: 28465428.
      View in: PubMed
    3. Koelsch KK, Rasmussen TA, Hey-Nguyen WJ, Pearson C, Xu Y, Bailey M, Marks KH, Sasson SC, Taylor MS, Tantau R, Obeid S, Milner B, Morrissey CO, Pinto AN, Suzuki K, Busch MP, Keating SM, Kaiser P, Yukl S, Wong JK, Hiener BM, Palmer S, Zaunders J, Post JJ, Chan DJ, Avery S, Milliken ST, Kelleher AD, Lewin SR, Cooper DA. Impact of allogeneic hematopoietic stem cell transplantation on the HIV reservoir and immune response in three HIV infected individuals. J Acquir Immune Defic Syndr. 2017 Mar 24. PMID: 28350553.
      View in: PubMed
    4. Kaiser P, Joshi SK, Kim P, Li P, Liu H, Rice AP, Wong JK, Yukl SA. Assays for precise quantification of total (including short) and elongated HIV-1 transcripts. J Virol Methods. 2016 Dec 27; 242:1-8. PMID: 28034670.
      View in: PubMed
    5. Wong JK, Yukl SA. Tissue reservoirs of HIV. Curr Opin HIV AIDS. 2016 Jul; 11(4):362-70. PMID: 27259045.
      View in: PubMed
    6. Li P, Kaiser P, Lampiris HW, Kim P, Yukl SA, Havlir DV, Greene WC, Wong J, et al. Stimulating the RIG-I pathway to kill cells in the latent HIV reservoir following viral reactivation. Nat Med. 2016 Jul; 22(7):807-11. PMID: 27294875.
      View in: PubMed
    7. Ma Q, Vaida F, Wong J, Sanders CA, Kao YT, Croteau D, Clifford DB, Collier AC, Gelman BB, Marra CM, McArthur JC, Morgello S, Simpson DM, Heaton RK, Grant I, Letendre SL. Long-term efavirenz use is associated with worse neurocognitive functioning in HIV-infected patients. J Neurovirol. 2016 Apr; 22(2):170-8. PMID: 26407716; PMCID: PMC4783211 [Available on 04/01/17].
    8. Jiang G, Mendes EA, Kaiser P, Wong DP, Tang Y, Cai I, Fenton A, Melcher GP, Hildreth JE, Thompson GR, Wong JK, Dandekar S. Synergistic Reactivation of Latent HIV Expression by Ingenol-3-Angelate, PEP005, Targeted NF-kB Signaling in Combination with JQ1 Induced p-TEFb Activation. PLoS Pathog. 2015 Jul; 11(7):e1005066. PMID: 26225771; PMCID: PMC4520526.
    9. Yukl SA, Shergill AK, Girling V, Li Q, Killian M, Epling L, Li P, Kaiser P, Haase A, Havlir DV, McQuaid K, Sinclair E, Wong JK. Site-specific differences in T cell frequencies and phenotypes in the blood and gut of HIV-uninfected and ART-treated HIV+ adults. PLoS One. 2015; 10(3):e0121290. PMID: 25811360; PMCID: PMC4374729.
    10. Chartier M, Crouch PC, Tullis V, Catella S, Frawley E, Filanosky C, Carmody T, McQuaid J, Lampiris H, Wong JK. The Montreal Cognitive Assessment: A Pilot Study of a Brief Screening Tool for Mild and Moderate Cognitive Impairment in HIV-Positive Veterans. J Int Assoc Provid AIDS Care. 2015 May-Jun; 14(3):197-201. PMID: 25487428.
      View in: PubMed
    11. Abdel-Mohsen M, Deng X, Danesh A, Liegler T, Jacobs ES, Rauch A, Ledergerber B, Norris PJ, Günthard HF, Wong JK, Pillai SK. Role of microRNA modulation in the interferon-a/ribavirin suppression of HIV-1 in vivo. PLoS One. 2014; 9(10):e109220. PMID: 25275557; PMCID: PMC4183579.
    12. Jiang G, Mendes EA, Kaiser P, Sankaran-Walters S, Tang Y, Weber MG, Melcher GP, Thompson GR, Tanuri A, Pianowski LF, Wong JK, Dandekar S. Reactivation of HIV latency by a newly modified Ingenol derivative via protein kinase Cd-NF-?B signaling. AIDS. 2014 Jul 17; 28(11):1555-66. PMID: 24804860.
      View in: PubMed
    13. Li P, Fujimoto K, Bourguingnon L, Yukl S, Deeks S, Wong JK. Exogenous and endogenous hyaluronic acid reduces HIV infection of CD4(+) T cells. Immunol Cell Biol. 2014 Oct; 92(9):770-80. PMID: 24957217; PMCID: PMC4205896.
    14. Liegler T, Abdel-Mohsen M, Bentley LG, Atchison R, Schmidt T, Javier J, Mehrotra M, Eden C, Glidden DV, McMahan V, Anderson PL, Li P, Wong JK, Buchbinder S, Guanira JV, Grant RM. HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial. J Infect Dis. 2014 Oct 15; 210(8):1217-27. PMID: 24740633; PMCID: PMC4176446.
    15. Yukl SA, Kaiser P, Kim P, Li P, Wong JK. Advantages of using the QIAshredder instead of restriction digestion to prepare DNA for droplet digital PCR. Biotechniques. 2014; 56(4):194-6. PMID: 24724845.
      View in: PubMed
    16. Dunham RM, Vujkovic-Cvijin I, Yukl SA, Broadhurst MJ, Loke P, Albright RG, Wong JK, Lederman MM, Somsouk M, Hunt PW, Martin JN, Deeks SG, McCune JM. Discordance between peripheral and colonic markers of inflammation during suppressive ART. J Acquir Immune Defic Syndr. 2014 Feb 1; 65(2):133-41. PMID: 24121758; PMCID: PMC3997573.
    17. Yukl SA, Sinclair E, Somsouk M, Hunt PW, Epling L, Killian M, Girling V, Li P, Havlir DV, Deeks SG, Wong JK, Hatano H. A comparison of methods for measuring rectal HIV levels suggests that HIV DNA resides in cells other than CD4+ T cells, including myeloid cells. AIDS. 2014 Jan 28; 28(3):439-42. PMID: 24322272; PMCID: PMC4130176.
    18. Moyers BS, Secemsky EA, Vittinghoff E, Wong JK, Havlir DV, Hsue PY, Tseng ZH. Effect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virus. Am J Cardiol. 2014 Apr 1; 113(7):1260-5. PMID: 24521717; PMCID: PMC3959566.
    19. McDermott GP, Do D, Litterst CM, Maar D, Hindson CM, Steenblock ER, Legler TC, Jouvenot Y, Marrs SH, Bemis A, Shah P, Wong J, Wang S, Sally D, Javier L, Dinio T, Han C, Brackbill TP, Hodges SP, Ling Y, Klitgord N, Carman GJ, Berman JR, Koehler RT, Hiddessen AL, Walse P, Bousse L, Tzonev S, Hefner E, Hindson BJ, Cauly TH, Hamby K, Patel VP, Regan JF, Wyatt PW, Karlin-Neumann GA, Stumbo DP, Lowe AJ. Multiplexed target detection using DNA-binding dye chemistry in droplet digital PCR. Anal Chem. 2013 Dec 3; 85(23):11619-27. PMID: 24180464.
      View in: PubMed
    20. Abdel-Mohsen M, Deng X, Liegler T, Guatelli JC, Salama MS, Ghanem Hel-D, Rauch A, Ledergerber B, Deeks SG, Günthard HF, Wong JK, Pillai SK. Effects of alpha interferon treatment on intrinsic anti-HIV-1 immunity in vivo. J Virol. 2014 Jan; 88(1):763-7. PMID: 24155399; PMCID: PMC3911728.
    21. Abdel-Mohsen M, Raposo RA, Deng X, Li M, Liegler T, Sinclair E, Salama MS, Ghanem Hel-D, Hoh R, Wong JK, David M, Nixon DF, Deeks SG, Pillai SK. Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology. 2013; 10:106. PMID: 24131498; PMCID: PMC3827935.
    22. Hatano H, Yukl SA, Ferre AL, Graf EH, Somsouk M, Sinclair E, Abdel-Mohsen M, Liegler T, Harvill K, Hoh R, Palmer S, Bacchetti P, Hunt PW, Martin JN, McCune JM, Tracy RP, Busch MP, O'Doherty U, Shacklett BL, Wong JK, Deeks SG. Prospective antiretroviral treatment of asymptomatic, HIV-1 infected controllers. PLoS Pathog. 2013; 9(10):e1003691. PMID: 24130489; PMCID: PMC3795031.
    23. Hatano H, Somsouk M, Sinclair E, Harvill K, Gilman L, Cohen M, Hoh R, Hunt PW, Martin JN, Wong JK, Deeks SG, Yukl SA. Comparison of HIV DNA and RNA in gut-associated lymphoid tissue of HIV-infected controllers and noncontrollers. AIDS. 2013 Sep 10; 27(14):2255-60. PMID: 24157906; PMCID: PMC4143147.
    24. Yukl SA, Shergill AK, Ho T, Killian M, Girling V, Epling L, Li P, Wong LK, Crouch P, Deeks SG, Havlir DV, McQuaid K, Sinclair E, Wong JK. The distribution of HIV DNA and RNA in cell subsets differs in gut and blood of HIV-positive patients on ART: implications for viral persistence. J Infect Dis. 2013 Oct 15; 208(8):1212-20. PMID: 23852128; PMCID: PMC3778964.
    25. Yukl SA, Boritz E, Busch M, Bentsen C, Chun TW, Douek D, Eisele E, Haase A, Ho YC, Hütter G, Justement JS, Keating S, Lee TH, Li P, Murray D, Palmer S, Pilcher C, Pillai S, Price RW, Rothenberger M, Schacker T, Siliciano J, Siliciano R, Sinclair E, Strain M, Wong J, Richman D, Deeks SG. Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient. PLoS Pathog. 2013; 9(5):e1003347. PMID: 23671416; PMCID: PMC3649997.
    26. Eriksson S, Graf EH, Dahl V, Strain MC, Yukl SA, Lysenko ES, Bosch RJ, Lai J, Chioma S, Emad F, Abdel-Mohsen M, Hoh R, Hecht F, Hunt P, Somsouk M, Wong J, Johnston R, Siliciano RF, Richman DD, O'Doherty U, Palmer S, Deeks SG, Siliciano JD. Comparative analysis of measures of viral reservoirs in HIV-1 eradication studies. PLoS Pathog. 2013 Feb; 9(2):e1003174. PMID: 23459007; PMCID: PMC3573107.
    27. Jain V, Liegler T, Kabami J, Chamie G, Clark TD, Black D, Geng EH, Kwarisiima D, Wong JK, Abdel-Mohsen M, Sonawane N, Aweeka FT, Thirumurthy H, Petersen ML, Charlebois ED, Kamya MR, Havlir DV. Assessment of population-based HIV RNA levels in a rural east African setting using a fingerprick-based blood collection method. Clin Infect Dis. 2013 Feb; 56(4):598-605. PMID: 23243180; PMCID: PMC3552523.
    28. Hightower GK, Wong JK, Letendre SL, Umlauf AA, Ellis RJ, Ignacio CC, Heaton RK, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Grant I, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM. Higher HIV-1 genetic diversity is associated with AIDS and neuropsychological impairment. Virology. 2012 Nov 25; 433(2):498-505. PMID: 22999095; PMCID: PMC3466337.
    29. Tseng ZH, Secemsky EA, Dowdy D, Vittinghoff E, Moyers B, Wong JK, Havlir DV, Hsue PY. Sudden cardiac death in patients with human immunodeficiency virus infection. J Am Coll Cardiol. 2012 May 22; 59(21):1891-6. PMID: 22595409; PMCID: PMC3356565.
    30. Choi JY, Hightower GK, Wong JK, Heaton R, Woods S, Grant I, Marcotte TD, Ellis RJ, Letendre SL, Collier AC, Marra CM, Clifford DB, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Richman DD, Smith DM. Genetic features of cerebrospinal fluid-derived subtype B HIV-1 tat. J Neurovirol. 2012 Apr; 18(2):81-90. PMID: 22528397; PMCID: PMC3572198.
    31. Pillai SK, Abdel-Mohsen M, Guatelli J, Skasko M, Monto A, Fujimoto K, Yukl S, Greene WC, Kovari H, Rauch A, Fellay J, Battegay M, Hirschel B, Witteck A, Bernasconi E, Ledergerber B, Günthard HF, Wong JK. Role of retroviral restriction factors in the interferon-a-mediated suppression of HIV-1 in vivo. Proc Natl Acad Sci U S A. 2012 Feb 21; 109(8):3035-40. PMID: 22315404; PMCID: PMC3286922.
    32. Ruel TD, Boivin MJ, Boal HE, Bangirana P, Charlebois E, Havlir DV, Rosenthal PJ, Dorsey G, Achan J, Akello C, Kamya MR, Wong JK. Neurocognitive and motor deficits in HIV-infected Ugandan children with high CD4 cell counts. Clin Infect Dis. 2012 Apr; 54(7):1001-9. PMID: 22308272; PMCID: PMC3297647.
    33. Yukl SA, Li P, Fujimoto K, Lampiris H, Lu CM, Hare CB, Deeks SG, Liegler T, Pandori M, Havlir DV, Wong JK. Modification of the Abbott RealTime assay for detection of HIV-1 plasma RNA viral loads less than one copy per milliliter. J Virol Methods. 2011 Aug; 175(2):261-5. PMID: 21536073; PMCID: PMC3827908.
    34. Lerner P, Guadalupe M, Donovan R, Hung J, Flamm J, Prindiville T, Sankaran-Walters S, Syvanen M, Wong JK, George MD, Dandekar S. The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy. J Virol. 2011 May; 85(10):4772-82. PMID: 21345945; PMCID: PMC3126205.
    35. Ruel TD, Kamya MR, Li P, Pasutti W, Charlebois ED, Liegler T, Dorsey G, Rosenthal PJ, Havlir DV, Wong JK, Achan J. Early virologic failure and the development of antiretroviral drug resistance mutations in HIV-infected Ugandan children. J Acquir Immune Defic Syndr. 2011 Jan 1; 56(1):44-50. PMID: 21099693; PMCID: PMC3078046.
    36. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol. 2011 Feb; 17(1):3-16. PMID: 21174240; PMCID: PMC3032197.
    37. Heaton RK, Clifford DB, Franklin DR, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010 Dec 7; 75(23):2087-96. PMID: 21135382; PMCID: PMC2995535.
    38. Yukl SA, Shergill AK, McQuaid K, Gianella S, Lampiris H, Hare CB, Pandori M, Sinclair E, Günthard HF, Fischer M, Wong JK, Havlir DV. Effect of raltegravir-containing intensification on HIV burden and T-cell activation in multiple gut sites of HIV-positive adults on suppressive antiretroviral therapy. AIDS. 2010 Oct 23; 24(16):2451-60. PMID: 20827162; PMCID: PMC2997807.
    39. Yukl SA, Gianella S, Sinclair E, Epling L, Li Q, Duan L, Choi AL, Girling V, Ho T, Li P, Fujimoto K, Lampiris H, Hare CB, Pandori M, Haase AT, Günthard HF, Fischer M, Shergill AK, McQuaid K, Havlir DV, Wong JK. Differences in HIV burden and immune activation within the gut of HIV-positive patients receiving suppressive antiretroviral therapy. J Infect Dis. 2010 Nov 15; 202(10):1553-61. PMID: 20939732; PMCID: PMC2997806.
    40. Li P, Ruel T, Fujimoto K, Hatano H, Yukl S, Eller LA, Liegler T, Kamya M, Gassasira A, Dorsey G, Rosenthal PJ, Havlir DV, Wong JK. Novel application of Locked Nucleic Acid chemistry for a Taqman assay for measuring diverse human immunodeficiency virus type 1 subtypes. J Virol Methods. 2010 Dec; 170(1-2):115-20. PMID: 20863855; PMCID: PMC3280821.
    41. Boivin MJ, Ruel TD, Boal HE, Bangirana P, Cao H, Eller LA, Charlebois E, Havlir DV, Kamya MR, Achan J, Akello C, Wong JK. HIV-subtype A is associated with poorer neuropsychological performance compared with subtype D in antiretroviral therapy-naive Ugandan children. AIDS. 2010 May 15; 24(8):1163-70. PMID: 20425886; PMCID: PMC2880483.
    42. Robertson K, Liner J, Hakim J, Sankalé JL, Grant I, Letendre S, Clifford D, Diop AG, Jaye A, Kanmogne G, Njamnshi A, Langford TD, Weyessa TG, Wood C, Banda M, Hosseinipour M, Sacktor N, Nakasuja N, Bangirana P, Paul R, Joska J, Wong J, Boivin M, Holding P, Kammerer B, Van Rie A, Ive P, Nath A, Lawler K, Adebamowo C, Royal W, Joseph J. NeuroAIDS in Africa. J Neurovirol. 2010 May; 16(3):189-202. PMID: 20500018; PMCID: PMC3549534.
    43. Wong JK, Strain MC, Porrata R, Reay E, Sankaran-Walters S, Ignacio CC, Russell T, Pillai SK, Looney DJ, Dandekar S. In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells. PLoS Pathog. 2010 Jan; 6(1):e1000748. PMID: 20126442; PMCID: PMC2813272.
    44. Joos B, Rieder P, Fischer M, Kuster H, Rusert P, Trkola A, Pillai SK, Wong JK, Weber R, Günthard HF. Association between specific HIV-1 Env traits and virologic control in vivo. Infect Genet Evol. 2010 Apr; 10(3):365-72. PMID: 19524069; PMCID: PMC3918463.
    45. Ruel T, Ssewanyana I, Achan J, Gasasira A, Kamya MR, Kekitiinwa A, Wong JK, Cao H, Havlir D, Charlebois ED. Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children. Clin Immunol. 2009 Jun; 131(3):410-4. PMID: 19303366; PMCID: PMC3032795.
    46. Yukl S, Pillai S, Li P, Chang K, Pasutti W, Ahlgren C, Havlir D, Strain M, Günthard H, Richman D, Rice AP, Daar E, Little S, Wong JK. Latently-infected CD4+ T cells are enriched for HIV-1 Tat variants with impaired transactivation activity. Virology. 2009 Apr 25; 387(1):98-108. PMID: 19268337; PMCID: PMC4474533.
    47. Smith DM, Zárate S, Shao H, Pillai SK, Letendre SL, Wong JK, Richman DD, Frost SD, Ellis RJ. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology. 2009 Mar 1; 385(1):204-8. PMID: 19100592; PMCID: PMC2794037.
    48. Srikantiah P, Wong JK, Liegler T, Walusimbi M, Mayanja-Kizza H, Kayanja HK, Mugerwa RD, Charlebois ED, Boom WH, Whalen CC, Havlir DV. Unexpected low-level viremia among HIV-infected Ugandan adults with untreated active tuberculosis. J Acquir Immune Defic Syndr. 2008 Dec 1; 49(4):458-60. PMID: 19011423.
      View in: PubMed
    49. Joos B, Fischer M, Kuster H, Pillai SK, Wong JK, Böni J, Hirschel B, Weber R, Trkola A, Günthard HF. HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc Natl Acad Sci U S A. 2008 Oct 28; 105(43):16725-30. PMID: 18936487; PMCID: PMC2575487.
    50. Kosakovsky Pond SL, Poon AF, Zárate S, Smith DM, Little SJ, Pillai SK, Ellis RJ, Wong JK, Leigh Brown AJ, Richman DD, Frost SD. Estimating selection pressures on HIV-1 using phylogenetic likelihood models. Stat Med. 2008 Oct 15; 27(23):4779-89. PMID: 18381707; PMCID: PMC2634745.
    51. Ruel TD, Achan J, Gasasira AF, Charlebois ED, Mehbratu T, Rosenthal PJ, Dorsey G, Kamya MR, Kekitiinwa A, Wong J, Havlir DV. HIV RNA suppression among HIV-infected Ugandan children with measles. J Acquir Immune Defic Syndr. 2008 Jun 1; 48(2):225-7. PMID: 18520684; PMCID: PMC3040680.
    52. Little SJ, Frost SD, Wong JK, Smith DM, Pond SL, Ignacio CC, Parkin NT, Petropoulos CJ, Richman DD. Persistence of transmitted drug resistance among subjects with primary human immunodeficiency virus infection. J Virol. 2008 Jun; 82(11):5510-8. PMID: 18353964; PMCID: PMC2395184.
    53. Pilcher CD, Wong JK, Pillai SK. Inferring HIV transmission dynamics from phylogenetic sequence relationships. PLoS Med. 2008 Mar 18; 5(3):e69. PMID: 18351799; PMCID: PMC2267810.
    54. Pillai SK, Wong JK, Barbour JD. Turning up the volume on mutational pressure: is more of a good thing always better? (A case study of HIV-1 Vif and APOBEC3). Retrovirology. 2008; 5:26. PMID: 18339206; PMCID: PMC2323022.
    55. Yukl S, Wong JK. Blood and guts and HIV: preferential HIV persistence in GI mucosa. J Infect Dis. 2008 Mar 1; 197(5):640-2. PMID: 18260765.
      View in: PubMed
    56. Koelsch KK, Liu L, Haubrich R, May S, Havlir D, Günthard HF, Ignacio CC, Campos-Soto P, Little SJ, Shafer R, Robbins GK, D'Aquila RT, Kawano Y, Young K, Dao P, Spina CA, Richman DD, Wong JK. Dynamics of total, linear nonintegrated, and integrated HIV-1 DNA in vivo and in vitro. J Infect Dis. 2008 Feb 1; 197(3):411-9. PMID: 18248304.
      View in: PubMed
    57. Smith DM, Wong JK, Shao H, Hightower GK, Mai SH, Moreno JM, Ignacio CC, Frost SD, Richman DD, Little SJ. Long-term persistence of transmitted HIV drug resistance in male genital tract secretions: implications for secondary transmission. J Infect Dis. 2007 Aug 1; 196(3):356-60. PMID: 17597449.
      View in: PubMed
    58. Joos B, Fischer M, Schweizer A, Kuster H, Böni J, Wong JK, Weber R, Trkola A, Günthard HF. Positive in vivo selection of the HIV-1 envelope protein gp120 occurs at surface-exposed regions. J Infect Dis. 2007 Jul 15; 196(2):313-20. PMID: 17570120.
      View in: PubMed
    59. Wong JK, Lampiris H. Covering all the bases: targeting HIV-1 integrase. J Acquir Immune Defic Syndr. 2006 Dec 15; 43(5):507-8. PMID: 17133210.
      View in: PubMed
    60. Smith DM, Strain MC, Frost SD, Pillai SK, Wong JK, Wrin T, Liu Y, Petropolous CJ, Daar ES, Little SJ, Richman DD. Lack of neutralizing antibody response to HIV-1 predisposes to superinfection. Virology. 2006 Nov 10; 355(1):1-5. PMID: 16962152.
      View in: PubMed
    61. Pillai SK, Pond SL, Liu Y, Good BM, Strain MC, Ellis RJ, Letendre S, Smith DM, Günthard HF, Grant I, Marcotte TD, McCutchan JA, Richman DD, Wong JK. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain. 2006 Jul; 129(Pt 7):1872-83. PMID: 16735456.
      View in: PubMed
    62. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Petropoulos CJ, Richman DD, Little SJ. HIV drug resistance acquired through superinfection. AIDS. 2005 Aug 12; 19(12):1251-6. PMID: 16052079.
      View in: PubMed
    63. Joos B, Trkola A, Fischer M, Kuster H, Rusert P, Leemann C, Böni J, Oxenius A, Price DA, Phillips RE, Wong JK, Hirschel B, Weber R, Günthard HF. Low human immunodeficiency virus envelope diversity correlates with low in vitro replication capacity and predicts spontaneous control of plasma viremia after treatment interruptions. J Virol. 2005 Jul; 79(14):9026-37. PMID: 15994796; PMCID: PMC1168724.
    64. Strain MC, Little SJ, Daar ES, Havlir DV, Gunthard HF, Lam RY, Daly OA, Nguyen J, Ignacio CC, Spina CA, Richman DD, Wong JK. Effect of treatment, during primary infection, on establishment and clearance of cellular reservoirs of HIV-1. J Infect Dis. 2005 May 1; 191(9):1410-8. PMID: 15809898.
      View in: PubMed
    65. Havlir DV, Koelsch KK, Strain MC, Margot N, Lu B, Ignacio CC, Miller MD, Wong JK. Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine. J Infect Dis. 2005 Apr 1; 191(7):1164-8. PMID: 15747253.
      View in: PubMed
    66. Pillai SK, Good B, Pond SK, Wong JK, Strain MC, Richman DD, Smith DM. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol. 2005 Feb; 79(3):1734-42. PMID: 15650198; PMCID: PMC544119.
    67. Strain MC, Letendre S, Pillai SK, Russell T, Ignacio CC, Günthard HF, Good B, Smith DM, Wolinsky SM, Furtado M, Marquie-Beck J, Durelle J, Grant I, Richman DD, Marcotte T, McCutchan JA, Ellis RJ, Wong J. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol. 2005 Feb; 79(3):1772-88. PMID: 15650202; PMCID: PMC544082.
    68. Smith DM, Wong JK, Hightower GK, Ignacio CC, Koelsch KK, Daar ES, Richman DD, Little SJ. Incidence of HIV superinfection following primary infection. JAMA. 2004 Sep 8; 292(10):1177-8. PMID: 15353529.
      View in: PubMed
    69. Smith DM, Kingery JD, Wong JK, Ignacio CC, Richman DD, Little SJ. The prostate as a reservoir for HIV-1. AIDS. 2004 Jul 23; 18(11):1600-2. PMID: 15238781.
      View in: PubMed
    70. Fischer M, Joos B, Wong JK, Ott P, Opravil M, Hirschel B, Weber R, Günthard HF. Attenuated and nonproductive viral transcription in the lymphatic tissue of HIV-1-infected patients receiving potent antiretroviral therapy. J Infect Dis. 2004 Jan 15; 189(2):273-85. PMID: 14722893.
      View in: PubMed
    71. Richman DD, Little SJ, Smith DM, Wrin T, Petropoulos C, Wong JK. HIV evolution and escape. Trans Am Clin Climatol Assoc. 2004; 115:289-303. PMID: 17060974; PMCID: PMC2263778.
    72. Havlir DV, Strain MC, Clerici M, Ignacio C, Trabattoni D, Ferrante P, Wong JK. Productive infection maintains a dynamic steady state of residual viremia in human immunodeficiency virus type 1-infected persons treated with suppressive antiretroviral therapy for five years. J Virol. 2003 Oct; 77(20):11212-9. PMID: 14512569; PMCID: PMC224988.
    73. Koelsch KK, Smith DM, Little SJ, Ignacio CC, Macaranas TR, Brown AJ, Petropoulos CJ, Richman DD, Wong JK. Clade B HIV-1 superinfection with wild-type virus after primary infection with drug-resistant clade B virus. AIDS. 2003 May 2; 17(7):F11-6. PMID: 12700477.
      View in: PubMed
    74. Strain MC, Günthard HF, Havlir DV, Ignacio CC, Smith DM, Leigh-Brown AJ, Macaranas TR, Lam RY, Daly OA, Fischer M, Opravil M, Levine H, Bacheler L, Spina CA, Richman DD, Wong JK. Heterogeneous clearance rates of long-lived lymphocytes infected with HIV: intrinsic stability predicts lifelong persistence. Proc Natl Acad Sci U S A. 2003 Apr 15; 100(8):4819-24. PMID: 12684537; PMCID: PMC153639.
    75. Strain MC, Richman DD, Wong JK, Levine H. Spatiotemporal dynamics of HIV propagation. J Theor Biol. 2002 Sep 7; 218(1):85-96. PMID: 12297072.
      View in: PubMed
    76. Fischer M, Wong JK, Russenberger D, Joos B, Opravil M, Hirschel B, Trkola A, Kuster H, Weber R, Günthard HF. Residual cell-associated unspliced HIV-1 RNA in peripheral blood of patients on potent antiretroviral therapy represents intracellular transcripts. Antivir Ther. 2002 Jun; 7(2):91-103. PMID: 12212929.
      View in: PubMed
    77. Appay V, Hansasuta P, Sutton J, Schrier RD, Wong JK, Furtado M, Havlir DV, Wolinsky SM, McMichael AJ, Richman DD, Rowland-Jones SL, Spina CA. Persistent HIV-1-specific cellular responses despite prolonged therapeutic viral suppression. AIDS. 2002 Jan 25; 16(2):161-70. PMID: 11807299.
      View in: PubMed
    78. Havlir DV, Bassett R, Levitan D, Gilbert P, Tebas P, Collier AC, Hirsch MS, Ignacio C, Condra J, Günthard HF, Richman DD, Wong JK. Prevalence and predictive value of intermittent viremia with combination hiv therapy. JAMA. 2001 Jul 11; 286(2):171-9. PMID: 11448280.
      View in: PubMed
    79. Frost SD, Günthard HF, Wong J, Havlir D, Richman DD, Leigh Brown AJ. Evidence for positive selection driving the evolution of HIV-1 env under potent antiviral therapy. Virology. 2001 Jun 5; 284(2):250-8. PMID: 11384224.
      View in: PubMed
    80. Günthard HF, Havlir DV, Fiscus S, Zhang ZQ, Eron J, Mellors J, Gulick R, Frost SD, Brown AJ, Schleif W, Valentine F, Jonas L, Meibohm A, Ignacio CC, Isaacs R, Gamagami R, Emini E, Haase A, Richman DD, Wong J. Residual human immunodeficiency virus (HIV) Type 1 RNA and DNA in lymph nodes and HIV RNA in genital secretions and in cerebrospinal fluid after suppression of viremia for 2 years. J Infect Dis. 2001 May 1; 183(9):1318-27. PMID: 11294662.
      View in: PubMed
    81. Schacker T, Little S, Connick E, Gebhard K, Zhang ZQ, Krieger J, Pryor J, Havlir D, Wong JK, Schooley RT, Richman D, Corey L, Haase AT. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J Infect Dis. 2001 Feb 15; 183(4):555-62. PMID: 11170980.
      View in: PubMed
    82. Brown AJ, Precious HM, Whitcomb JM, Wong JK, Quigg M, Huang W, Daar ES, D'Aquila RT, Keiser PH, Connick E, Hellmann NS, Petropoulos CJ, Richman DD, Little SJ. Reduced susceptibility of human immunodeficiency virus type 1 (HIV-1) from patients with primary HIV infection to nonnucleoside reverse transcriptase inhibitors is associated with variation at novel amino acid sites. J Virol. 2000 Nov; 74(22):10269-73. PMID: 11044070; PMCID: PMC110900.
    83. Günthard HF, Wong JK, Spina CA, Ignacio C, Kwok S, Christopherson C, Hwang J, Haubrich R, Havlir D, Richman DD. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis. 2000 Feb; 181(2):522-31. PMID: 10669335.
      View in: PubMed
    84. Precious HM, Günthard HF, Wong JK, D'Aquila RT, Johnson VA, Kuritzkes DR, Richman DD, Leigh Brown AJ. Multiple sites in HIV-1 reverse transcriptase associated with virological response to combination therapy. AIDS. 2000 Jan 7; 14(1):31-6. PMID: 10714565.
      View in: PubMed
    85. Schacker T, Little S, Connick E, Gebhard-Mitchell K, Zhang ZQ, Krieger J, Pryor J, Havlir D, Wong JK, Richman D, Corey L, Haase AT. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J Infect Dis. 2000 Jan; 181(1):354-7. PMID: 10608788.
      View in: PubMed
    86. Günthard HF, Frost SD, Leigh-Brown AJ, Ignacio CC, Kee K, Perelson AS, Spina CA, Havlir DV, Hezareh M, Looney DJ, Richman DD, Wong JK. Evolution of envelope sequences of human immunodeficiency virus type 1 in cellular reservoirs in the setting of potent antiviral therapy. J Virol. 1999 Nov; 73(11):9404-12. PMID: 10516049; PMCID: PMC112975.
    87. Brown AJ, Günthard HF, Wong JK, D'Aquila RT, Johnson VA, Kuritzkes DR, Richman DD. Sequence clusters in human immunodeficiency virus type 1 reverse transcriptase are associated with subsequent virological response to antiretroviral therapy. J Infect Dis. 1999 Oct; 180(4):1043-9. PMID: 10479129.
      View in: PubMed
    88. Günthard HF, Leigh-Brown AJ, D'Aquila RT, Johnson VA, Kuritzkes DR, Richman DD, Wong JK, D'aquila RT. Higher selection pressure from antiretroviral drugs in vivo results in increased evolutionary distance in HIV-1 pol. Virology. 1999 Jun 20; 259(1):154-65. PMID: 10364500.
      View in: PubMed
    89. Zhang ZQ, Schuler T, Cavert W, Notermans DW, Gebhard K, Henry K, Havlir DV, Günthard HF, Wong JK, Little S, Feinberg MB, Polis MA, Schrager LK, Schacker TW, Richman DD, Corey L, Danner SA, Haase AT. Reversibility of the pathological changes in the follicular dendritic cell network with treatment of HIV-1 infection. Proc Natl Acad Sci U S A. 1999 Apr 27; 96(9):5169-72. PMID: 10220437; PMCID: PMC21835.
    90. Günthard HF, Wong JK, Ignacio CC, Havlir DV, Richman DD. Comparative performance of high-density oligonucleotide sequencing and dideoxynucleotide sequencing of HIV type 1 pol from clinical samples. AIDS Res Hum Retroviruses. 1998 Jul 1; 14(10):869-76. PMID: 9671215.
      View in: PubMed
    91. Günthard HF, Wong JK, Ignacio CC, Guatelli JC, Riggs NL, Havlir DV, Richman DD. Human immunodeficiency virus replication and genotypic resistance in blood and lymph nodes after a year of potent antiretroviral therapy. J Virol. 1998 Mar; 72(3):2422-8. PMID: 9499103; PMCID: PMC109542.
    92. Wong JK, Hezareh M, Günthard HF, Havlir DV, Ignacio CC, Spina CA, Richman DD. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science. 1997 Nov 14; 278(5341):1291-5. PMID: 9360926.
      View in: PubMed
    93. Wong JK, Günthard HF, Havlir DV, Zhang ZQ, Haase AT, Ignacio CC, Kwok S, Emini E, Richman DD. Reduction of HIV-1 in blood and lymph nodes following potent antiretroviral therapy and the virologic correlates of treatment failure. Proc Natl Acad Sci U S A. 1997 Nov 11; 94(23):12574-9. PMID: 9356491; PMCID: PMC25043.
    94. Wong JK, Ignacio CC, Torriani F, Havlir D, Fitch NJ, Richman DD. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol. 1997 Mar; 71(3):2059-71. PMID: 9032338; PMCID: PMC191294.
    95. Hynd RF, Klofkorn RW, Wong JK. Streptococcus anginosus-constellatus infection of the sternoclavicular joint. J Rheumatol. 1984 Oct; 11(5):713-5. PMID: 6392552.
      View in: PubMed
    Joseph's Networks
    Concepts
    Derived automatically from this person's publications.
    _
    Co-Authors
    People in Profiles who have published with this person.
    _
    Related Authors
    People who share related concepts with this person.
    _
    Back to TOP